In addition, Ptgs2 is also responsible for the synthesis of inflammation-related PG, and the inhibition of PG and NO production has been proposed as a therapeutic target for inflammatory diseases, such as PD, Huntington’s disease and AD [54]. Here, PTGS2 is linked to juvenile Huntington disease.